20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters.

J Adv Res · 2025 · PMC12225906 · PMID 39270979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice treated with GEM showed a trend of resistance, whereas the combination of Rh2 and GEM exerted superior inhibitory effects on tumor growth compared to GEM or Rh2 alone ( Fig. 3 c-e ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.